Establishment of Stable Cell Lines With High Expression of Heterodimers of Human 4F2hc and Human Amino Acid Transporter LAT1 or LAT2 and Delineation of Their Differential Interaction With ^|^alpha;-Alkyl Moieties
Создание стабильных клеточных линий с высокой экспрессией гетеродимеров человеческого 4F2hc и человеческого транспортёра аминокислот LAT1 или LAT2 и определение их дифференциального взаимодействия с α-алкильными группами
2012-01-01
SCID: 54.1/64jfvkkn
Discuss with AI
4F2hc heterodimersHEK293 stable cell linesLAT1/LAT2 amino acid transportersSystem L amino acid transportα-alkyl amino acids
Figures from the paper
Abstract (AI)
System L is a major transport system for cellular uptake of neutral amino acids. Among system L transporters, L-type amino acid transporter 1 (LAT1) is responsible for the nutrient uptake in cancer cells, whereas L-type amino acid transporter 2 (LAT2) is a transporter for non-cancer cells. In this study, we have established HEK293 cell lines stably expressing high levels of human LAT1 and LAT2 forming heterodimers with native human 4F2hc of the cells. We have found that L-[(14)C]alanine is an appropriate substrate to examine the function of LAT2, whereas L-[(14)C]leucine is used for LAT1. By using L-[(14)C]alanine on LAT2, we have for the first time directly evaluated the function of human LAT2 expressed in mammalian cells and obtained its reliable kinetics. Using α-alkyl amino acids including α-methyl-alanine and α-ethyl-L-alanine, we have demonstrated that α-alkyl groups interfere with the interaction with LAT2. These cell lines with higher practical advantages would be useful for screening and analyzing compounds to develop LAT1-specific drugs that can be used for cancer diagnosis and therapeutics. The strategy that we took to establish the cell lines would also be applicable to the other heterodimeric transporters with important therapeutic implications.
Key Findings
1
L-[14C]alanine was identified as a suitable substrate for assessing LAT2 function, while L-[14C]leucine was used for LAT1.
2
Stable HEK293 cell lines were established that highly express human LAT1 or LAT2 heterodimers with endogenous human 4F2hc.
3
The established cell lines provide practical systems for screening LAT1-specific drug candidates and may support studies of other therapeutically relevant heterodimeric transporters.
4
The study directly evaluated human LAT2 function in mammalian cells for the first time and obtained reliable kinetic parameters.
5
α-Alkyl amino acids, including α-methyl-alanine and α-ethyl-L-alanine, interfere with substrate interaction with LAT2.
Research Object
HEK293 cell lines stably expressing human LAT1 or LAT2 heterodimerized with native human 4F2hc
Research Subject
The transport function and kinetics of LAT1/LAT2 and their differential interaction with α-alkyl amino acids, including the interference caused by α-alkyl groups with LAT2
Publication Details
Publication Date
2012-01-01
Journal
Publisher
ISSN
Cited by
79
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
Cited by5
Novel cystine transporter in renal proximal tubule identified as a missing partner of cystinuria-related plasma membrane protein rBAT/SLC3A12016
Structure-activity relationship of a novel series of inhibitors for cancer type transporter L-type amino acid transporter 1 (LAT1)2017
Development of LAT1-Selective Nuclear Medicine Therapeutics Using Astatine-2112024
Modulation of LAT1 (SLC7A5) transporter activity and stability by membrane cholesterol2017
Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB 0,+ , LAT 1 and LAT 22015